colestipol has been researched along with Dyslipidemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Insull, W | 1 |
| Brown, BG; Brunzell, JD; Hokanson, JE; Motulsky, AG; Zambon, A | 1 |
1 review(s) available for colestipol and Dyslipidemia
| Article | Year |
|---|---|
Clinical utility of bile acid sequestrants in the treatment of dyslipidemia: a scientific review.
Topics: Allylamine; Bile Acids and Salts; Cholesterol; Colesevelam Hydrochloride; Colestipol; Dyslipidemias; Humans; Hypolipidemic Agents; Lipids; Treatment Outcome | 2006 |
1 trial(s) available for colestipol and Dyslipidemia
| Article | Year |
|---|---|
Genetically determined apo B levels and peak LDL density predict angiographic response to intensive lipid-lowering therapy.
Topics: Adult; Analysis of Variance; Apolipoproteins B; Colestipol; Coronary Angiography; Coronary Stenosis; Drug Therapy, Combination; Dyslipidemias; Genetic Predisposition to Disease; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipoproteins, LDL; Lovastatin; Male; Middle Aged; Niacin; Pharmacogenetics; Treatment Outcome | 2006 |